Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1992
Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis
S Yamada, T Yamamoto, T Suou, et al.
Journal of Hepatology
|
November 19, 1997
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
G Shiota, Y Kishimoto, A Suyama, et al.
Liver
|
October 9, 2001
Inclusion body myositis associated with hepatitis C virus infection
S Kase, G Shiota, Y Fujii, et al.
Liver
|
November 25, 2000
Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patients with "latent" chronic hepatitis B
G Shiota, K Harada, K Oyama, et al.
Journal of Medical Virology
|
September 26, 2000
Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53
G Shiota, K Oyama, A Udagawa, et al.
Oncology
|
July 8, 1999
Prognosis for pedunculated hepatocellular carcinoma
Y Horie, A Shigoku, H Tanaka, et al.
Research Communications in Molecular Pathology and Pharmacology
|
April 2, 1998
Clinical significance of serum P53 antibody in patients with gastric cancer
G Shiota, M Ishida, N Noguchi, et al.
Digestive Diseases and Sciences
|
March 1, 2000
Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival
G Shiota, M Ishida, N Noguchi, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1992
Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis
S Yamada, T Yamamoto, T Suou, et al.
Journal of Hepatology
|
November 19, 1997
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
G Shiota, Y Kishimoto, A Suyama, et al.
Liver
|
October 9, 2001
Inclusion body myositis associated with hepatitis C virus infection
S Kase, G Shiota, Y Fujii, et al.
Liver
|
November 25, 2000
Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patients with "latent" chronic hepatitis B
G Shiota, K Harada, K Oyama, et al.
Journal of Medical Virology
|
September 26, 2000
Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53
G Shiota, K Oyama, A Udagawa, et al.
Oncology
|
July 8, 1999
Prognosis for pedunculated hepatocellular carcinoma
Y Horie, A Shigoku, H Tanaka, et al.
Research Communications in Molecular Pathology and Pharmacology
|
April 2, 1998
Clinical significance of serum P53 antibody in patients with gastric cancer
G Shiota, M Ishida, N Noguchi, et al.
Digestive Diseases and Sciences
|
March 1, 2000
Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival
G Shiota, M Ishida, N Noguchi, et al.
Page
of 7